Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
NCT ID: NCT01799395
Last Updated: 2017-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
45 participants
OBSERVATIONAL
2013-02-28
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the present study is to determine the prevalence at the time of diagnosis, the incidence at 1 year from the diagnosis, and the predictors of central airway obstruction associated with advanced lung cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Central Malignant Airway Obstructions: Medical Treatment Alone Versus Endoscopic and Medical Treatmen
NCT03903315
Recovery and Rehabilitation After Lung Cancer Surgery
NCT01399541
A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases
NCT03427541
Sleep Apnea in Lung Cancer: A Prospective Study
NCT02764866
Bronchial Mapping (GCC 1635)
NCT02745548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lung Cancer
All patients with advanced lung cancer candidate for chemotherapy or chemotherapy + radiation therapy will be enrolled and followed-up for 1 year clinically and radiologically (Chest CT) to verify whether or not central airway obstruction is present at the time of diagnosis or occurs in the year following diagnosis (or in the life span from diagnosis and death in patients who die before 1 year of diagnosis). Furthermore, predictor variables possibly associated with central airway obstruction will be studied.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Refusal to sign informed consent
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maggiore Bellaria Hospital, Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rocco Trisolini
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rocco Trisolini, M.D.
Role: PRINCIPAL_INVESTIGATOR
Maggiore Bellaria Hospital, Bologna, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bentivoglio Hospital
Bentivoglio, Emilia-Romagna, Italy
Bellaria Hospital
Bologna, Emilia-Romagna, Italy
Maggiore Hospital
Bologna, Emilia-Romagna, Italy
Budrio Hospital
Budrio, Emilia-Romagna, Italy
SS Salvatore Hospital
San Giovanni in Persiceto, Emilia-Romagna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13002-Trisolini
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.